Paper Details

  1. Home
  2. Paper Details

Ticagrelor: A Rare, Delayed Case of Angioedema.

Author: AlamAmmar, DalyTimothy, KearneyShannon, PrenattZarian, WaliaJasmit

Case ReportsIn the medical field, a report that describes in detail a unique case, an unusual medical condition, or the effect of a treatment. Provides new insights and possibilities for treatment through individual patient cases.

Overview

Dual antiplatelet therapy (DAPT) is the standard treatment for patients with acute coronary syndrome (ACS) and stent thrombosis after percutaneous coronary intervention (PCI). This case report describes a patient who experienced delayed-onset ticagrelor-induced angioedema three weeks after initiation of DAPT with aspirin and ticagrelor. This rare case highlights the importance of clinicians being aware of this potential adverse effect and its management.
Paper Details　
Original Abstract of the Article :
Dual antiplatelet therapy (DAPT) with P2Y12 receptor inhibitors in conjunction with aspirin is the gold standard treatment for acute coronary syndrome (ACS) and to prevent stent thrombosis after percutaneous coronary intervention (PCI). While there have been reported allergic effects-particularly an...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10243224/

データ提供：米国国立医学図書館（NLM）

Ticagrelor: A Rare Case of Angioedema

Angioedema, a swelling of the tissues, can be a frightening experience, like a sudden sandstorm obscuring the landscape. This study reports a rare case of delayed-onset angioedema associated with ticagrelor, a medication used to prevent blood clots. The study highlights the importance of recognizing this potential adverse effect, particularly given the rarity of this condition and the potential for delayed onset.

A Rare but Important Adverse Effect

This study reports a rare case of delayed-onset angioedema associated with ticagrelor, a medication used to prevent blood clots. The study's findings underscore the importance of recognizing this potential adverse effect, particularly given the rarity of this condition and the potential for delayed onset.

Navigating the Risks of Ticagrelor

This research highlights the importance of recognizing the potential for angioedema, a rare but important adverse effect associated with ticagrelor. The study's findings emphasize the need for careful monitoring and prompt management of this condition, ensuring the safety and well-being of patients receiving this medication.

Dr.Camel's Conclusion

This case report serves as a reminder of the importance of recognizing rare but potentially serious adverse effects associated with medications. The study highlights the need for continued vigilance in monitoring patient responses to medications, ensuring the safety and well-being of those receiving treatment.
Date :
  1. Date Completed n.d.
  2. Date Revised 2023-06-10
Further Info :

Pubmed ID

37288188

DOI: Digital Object Identifier

PMC10243224

Related Literature

Article Analysis
・Side Effects of prasugrel
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.